Melanotan-2 (MT-2) is a synthetic analogue of the alpha-melanocyte-stimulating hormone (α-MSH). Developed in the 1980s, it has been shown to increase sexual arousal, reduce compulsive/addictive behavior, curb hunger, and boost melanin production. Research has demonstrated that the peptide stimulates melanocytes, leading to greater skin pigmentation, and may help combat autism when used during early childhood development.
What is Melanotan-2 (MT-2)?
Melanotan-2 (MT-2) is a synthetic variant of the human alpha-melanocyte-stimulating hormone (α-MSH). It was developed in the 1980s at the University of Arizona, where researchers found that α-MSH induced sexual arousal in rodents and darkened the skin. Initially intended as a sunless tanning solution, MT-2 eventually revealed a wide range of effects, including:
- Increased sexual arousal
- Promoted skin tanning or pigmentation
- Reduced compulsive behavior
- Helped control addiction
- Suppressed hunger
- Reduced glucagon production
- Reversed certain characteristics of autism
Melatonan-2 | Peptide
Freedom Research
Melanotan-2 (MT-2) is typically administered via subcutaneous injections, with a common dosage of 0.25 to 1 mg per day. It is usually injected once or twice daily, depending on individual goals. For optimal results, MT-2 should be used in cycles, typically 4-6 weeks. Always consult a healthcare professional to determine the proper dosage and ensure safety.